GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Viatris Inc (XTER:VIA) » Definitions » Cyclically Adjusted Book per Share

Viatris (XTER:VIA) Cyclically Adjusted Book per Share : €22.49 (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Viatris Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Viatris's adjusted book value per share for the three months ended in Mar. 2025 was €12.208. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €22.49 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Viatris's average Cyclically Adjusted Book Growth Rate was 2.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.90% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.20% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Viatris was 18.80% per year. The lowest was 2.90% per year. And the median was 11.90% per year.

As of today (2025-05-29), Viatris's current stock price is €7.562. Viatris's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €22.49. Viatris's Cyclically Adjusted PB Ratio of today is 0.34.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Viatris was 8.32. The lowest was 0.31. And the median was 0.98.


Viatris Cyclically Adjusted Book per Share Historical Data

The historical data trend for Viatris's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viatris Cyclically Adjusted Book per Share Chart

Viatris Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.67 17.42 20.35 20.76 23.05

Viatris Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.60 21.81 21.43 23.05 22.49

Competitive Comparison of Viatris's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Viatris's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viatris's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Viatris's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Viatris's Cyclically Adjusted PB Ratio falls into.


;
;

Viatris Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Viatris's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book= Book Value per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=12.208/134.9266*134.9266
=12.208

Current CPI (Mar. 2025) = 134.9266.

Viatris Quarterly Data

Book Value per Share CPI Adj_Book
201506 17.343 100.684 23.241
201509 17.782 100.392 23.899
201512 18.270 99.792 24.702
201603 18.775 100.470 25.214
201606 18.083 101.688 23.994
201609 19.695 101.861 26.088
201612 19.685 101.863 26.075
201703 20.336 102.862 26.675
201706 21.304 103.349 27.813
201709 20.792 104.136 26.940
201712 21.451 104.011 27.827
201803 20.735 105.290 26.572
201806 20.272 106.317 25.727
201809 20.055 106.507 25.406
201812 20.735 105.998 26.394
201903 20.378 107.251 25.637
201906 20.420 108.070 25.495
201909 20.167 108.329 25.118
201912 20.722 108.420 25.788
202003 19.717 108.902 24.429
202006 20.177 108.767 25.030
202009 20.608 109.815 25.320
202012 15.634 109.897 19.195
202103 14.884 111.754 17.970
202106 14.556 114.631 17.133
202109 14.859 115.734 17.323
202112 14.995 117.630 17.200
202203 15.315 121.301 17.035
202206 15.453 125.017 16.678
202209 15.977 125.227 17.215
202212 16.389 125.222 17.659
202303 16.019 127.348 16.972
202306 16.043 128.729 16.815
202309 16.297 129.860 16.933
202312 15.631 129.419 16.296
202403 15.468 131.776 15.838
202406 15.197 132.554 15.469
202409 14.941 133.029 15.154
202412 14.910 133.157 15.108
202503 12.208 134.927 12.208

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Viatris  (XTER:VIA) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Viatris's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=7.562/22.49
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Viatris was 8.32. The lowest was 0.31. And the median was 0.98.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Viatris Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Viatris's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Viatris Business Description

Industry
Address
1000 Mylan Boulevard, Canonsburg, PA, USA, 15317
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.